OverviewChartNewsTraderScreen

UBS Knock-Out AMGN/  DE000UM0EQK6  /

EUWAX
28/06/2024  13:57:43 Chg.-0.02 Bid15:16:41 Ask15:16:41 Underlying Strike price Expiration date Option type
1.03EUR -1.90% 1.02
Bid Size: 50,000		 1.06
Ask Size: 50,000		 Amgen Inc 425.1419 USD 31/12/2078 Put
GlobeNewswire 27/06 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 27/06 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire 26/06 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 26/06 Compass Pathways appoints Lori Englebert as Chief Commercial Officer
GlobeNewswire 25/06 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
TeleTrader 24/06 US closes mostly lower, as energy, banking stocks take lead
GlobeNewswire 20/06 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 19/06 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 18/06 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 17/06 Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire 05/06 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 30/05 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 28/05 US markets turn to losses, Dow plunges 330 points
TeleTrader 28/05 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 28/05 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 27/05 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 23/05 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 21/05 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 21/05 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...
GlobeNewswire 21/05 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
TeleTrader 16/05 FDA approves Amgen's small cell lung cancer drug